Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

893 trials

NCT07229482
Recruiting
Potatoes, Type 2 Diabetes, and Cardiometabolic Health
Not applicable · United States · 1 site
Registry update: 3 Sept 2026
NCT07783802
Recruiting
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Phase 2 · Argentina, Japan, Puerto Rico, United States · 46 sites
Registry update: 3 Nov 2026
NCT07434791
Recruiting
Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)
Not applicable · Canada · 1 site
Registry update: 4 Sept 2026
NCT07747857
Recruiting
A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
Phase 1 · China · 12 sites
Registry update: 28 Aug 2026
NCT07776509
Recruiting
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Phase 3 · Argentina, Brazil, Canada, China, Denmark, United Kingdom, Israel, Japan, Sweden, Türkiye, United States · 86 sites
Registry update: 9 Nov 2026
NCT07797335
Recruiting
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Phase 3 · Argentina, Bulgaria, Brazil, Canada, China, Czechia, Germany, Spain, United Kingdom, Greece, India, Italy, Mexico, Poland, United States · 330 sites
Registry update: 1 Sept 2026
NCT07754461
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Phase 3 · Australia, Canada, India, New Zealand, United States · 101 sites
Registry update: 29 Oct 2026
NCT07775404
Recruiting
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
Phase 3 · China, Hong Kong, Malaysia, Philippines, Thailand · 44 sites
Registry update: 9 Nov 2026
NCT07784270
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Phase 3 · Argentina, Australia, Canada, Chile, China, Germany, Spain, United Kingdom, Hungary, India, Japan, South Korea, Poland, Slovakia, Taiwan, United States · 190 sites
Registry update: 28 Oct 2026
NCT07784725
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Phase 3 · Argentina, Australia, Bulgaria, Brazil, Canada, China, Czechia, Germany, France, India, Italy, Japan, South Korea, Poland, Taiwan, United States · 216 sites
Registry update: 30 Oct 2026
NCT07463209
Recruiting
Integrating New Skills Into Diabetes Education With CGM
Not applicable · United States · 1 site
Registry update: 5 Oct 2026
2025-524688-19-00
Recruiting
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Phase 3 · Germany, Spain, Italy, Poland · 64 sites
Registry update: 8 Sept 2026
NCT07563699
Recruiting
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
Phase 1/2 · Israel · 1 site
Registry update: 20 Aug 2026
NCT07812623
Recruiting
A Twelve-Week Pilot Study Evaluating the Usability and Preliminary Effects of SugarVita 2.0 in Adults With Type 2 Diabetes
Not applicable · Netherlands · 1 site
Registry update: 10 Sept 2026
NCT07448974
Recruiting
Vitamin D and Type 2 Diabetes - Treat-To-Target
Phase 3 · United States · 1 site
Registry update: 18 Aug 2026
NCT07282613
Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Phase 3 · Argentina, Brazil, Colombia, Israel, India, Mexico, Malaysia, Thailand, Taiwan, United States · 58 sites
Registry update: 19 Oct 2026
NCT07675499
Recruiting
Exercise and Intranasal Insulin in Type 2 Diabetes
Phase 2/3 · United States · 4 sites
Registry update: 30 Jun 2026
NCT07742917
Recruiting
Precision Lifestyle Medicine Program for IFHAS Participants
Not applicable · United Arab Emirates · 1 site
Registry update: 3 Aug 2026
NCT07852988
Recruiting
Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes
Phase 4 · Poland · 1 site
Registry update: 1 Oct 2026
NCT07731399
Recruiting
Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls
Not applicable · United States · 2 sites
Registry update: 18 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.